Log in

The full spectrum of MRI findings in 18 patients with Canavan disease: new insights into the areas of selective susceptibility

  • Paediatric Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Introduction

Canavan disease (CD) is a rare autosomal recessive neurodegenerative disorder caused by a deficiency of aspartoacylase A, an enzyme that degrades N-acetylaspartate (NAA). The disease is characterized by progressive white matter degeneration, leading to intellectual disability, seizures, and death. This retrospective study aims to describe the full spectrum of magnetic resonance imaging (MRI) findings in a large case series of CD patients.

Materials and methods

MRI findings in 18 patients with confirmed CD were investigated, and the full spectrum of brain abnormalities was compared with the existing literature to provide new insights regarding the brain MRI findings in these patients. All the cases were proven based on genetic study or NAA evaluation in urine or brain.

Results

Imaging analysis showed involvement of the deep and subcortical white matter as well as the globus pallidus in all cases, with sparing of the putamen, caudate, and claustrum. The study provides updates on the imaging characteristics of CD and validates some underreported findings such as the involvement of the lateral thalamus with sparing of the pulvinar, involvement of the internal capsules and corpus callosum, and cystic formation during disease progression.

Conclusion

To our knowledge, this is one of the largest case series of patients with CD which includes a detailed description of the brain MRI findings. The study confirmed many of the previously reported MRI findings but also identified abnormalities that were previously rarely or not described. We speculate that areas of ongoing myelination are particularly vulnerable to changes in CD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Rossler L et al (2023) Canavan’s spongiform leukodystrophy (aspartoacylase deficiency) with emphasis on sonographic features in infancy: description of a case report and review of the literature. J Ultrasound 26(4):757–764

    Article  PubMed  Google Scholar 

  2. Kamate M, Kabate V, Malhotra M (2016) Spongy White Matter: a Novel Neuroimaging finding in Canavan Disease. Pediatr Neurol 56:92–93

    Article  PubMed  Google Scholar 

  3. Baslow MH (2017) Rescuing Canavan disease: engineering the wrong cell at the right time. J Inherit Metab Dis 40(5):627–628

    Article  PubMed  Google Scholar 

  4. Feigenbaum A et al (2004) Canavan disease: carrier-frequency determination in the Ashkenazi jewish population and development of a novel molecular diagnostic assay. Am J Med Genet A 124A(2):142–147

    Article  PubMed  Google Scholar 

  5. Bokhari MR, Samanta D, Bokhari SRA (2024) Canavan Disease, in StatPearls. Treasure Island (FL)

  6. Merrill ST et al (2016) Cytotoxic edema and diffusion restriction as an early pathoradiologic marker in canavan disease: case report and review of the literature. Orphanet J Rare Dis 11(1):169

    Article  PubMed  PubMed Central  Google Scholar 

  7. Janson CG et al (2006) Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI. Neuropediatrics 37(4):209–221

    Article  CAS  PubMed  Google Scholar 

  8. Barkovich AJ, Raybaud C (2012) Pediatric Neuroimaging. Wolters Kluwer Health

  9. Pleasure D et al (2020) Pathophysiology and treatment of Canavan Disease. Neurochem Res 45(3):561–565

    Article  CAS  PubMed  Google Scholar 

  10. Rossi A, Biancheri R (2013) Magnetic resonance spectroscopy in metabolic disorders. Neuroimaging Clin N Am 23(3):425–448

    Article  PubMed  Google Scholar 

  11. n der Knaap MS, Valk J (2005) Magnetic resonance of myelination and myelin disorders. Springer, Berlin Heidelberg

    Book  Google Scholar 

  12. Gowda VK et al (2021) Canavan Disease: Clinical and Laboratory Profile from Southern Part of India. Ann Indian Acad Neurol 24(3):347–350

    Article  PubMed  Google Scholar 

  13. Sagar P, Grant PE (2006) Diffusion-weighted MR imaging: pediatric clinical applications. Neuroimaging Clin N Am, 16(1): pp. 45–74, viii

  14. Blaser S, Feigenbaum A (2004) A neuroimaging approach to inborn errors of metabolism. Neuroimaging Clin N Am, 14(2): p. 307 – 29, ix.

  15. Drenckhahn A, Schuelke M, Knierim E (2015) Leukodystrophy with multiple beaded periventricular cysts: unusual cranial MRI results in Canavan disease. J Inherit Metab Dis 38(5):983–984

    Article  PubMed  Google Scholar 

  16. Pradhan S, Goyal G (2011) Teaching NeuroImages: honeycomb appearance of the brain in a patient with Canavan disease. Neurology 76(13):e68

    Article  PubMed  Google Scholar 

  17. Moussa DM et al (2016) The role of MRI and MRS in the diagnosis of non hydrocephalic macrocrania in infancy and early childhood. Egypt J Radiol Nuclear Med 47:275–289

    Article  Google Scholar 

  18. Hoshino H, Kubota M (2014) Canavan disease: clinical features and recent advances in research. Pediatr Int 56(4):477–483

    Article  CAS  PubMed  Google Scholar 

  19. Gowda VK et al (2016) A case of Canavan disease with microcephaly. Brain Dev 38(8):759–762

    Article  PubMed  Google Scholar 

  20. Snell RS (2010) Clinical neuroanatomy. Wolters Kluwer Health/Lippincott Williams & Wilkins

Download references

Acknowledgements

We extend our sincere gratitude to the parents of patients for their invaluable contribution to data collection, even during challenging times. Special thanks are also due to our IT team, Mr. Majid Moazzami, and Mr. Ahmadali Parse, Head of the Anesthesiology team.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Ethics declarations

Ethical approval

All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional research committee (Clinical Research Adoption Committee) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Standard clinical informed consent was obtained at the time of the scan. Informed consent for this specific study was not applicable given the retrospective nature of this research.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rahimian, E., D’Arco, F., Sudhakar, S. et al. The full spectrum of MRI findings in 18 patients with Canavan disease: new insights into the areas of selective susceptibility. Neuroradiology (2024). https://doi.org/10.1007/s00234-024-03388-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00234-024-03388-x

Keywords

Navigation